The Leukemia Lymphoma Society was first founded in 1949, and has become the worlds largest organization focused on funding blood cancer research, education, and providing services for patients.
LLS’s goal is to find a cure to leukemia, lymphoma, Hodgkin’s disease, and myeloma, and to help improve the lives of patients and their families along the way.
LLS’s continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled.
Many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They’re even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis.
For more information about LLS, please visit lls.org